Campylobacter spp. - a significant microbiological hazard in food. II. Lesions and infection development, pathogenic mechanisms and complications

• Autorzy: Wysok B. , Uradzinski J.
• Języki publikacji: EN

Abstrakty

EN

Infections with Campylobacter spp. occur as a result of consumption of live cells with food. In developing countries those infections are immensely common, particularly during early childhood and 5 to 10 cases can appear during the initial two years of life. The symptoms appear usually after 1-7 days from infection depending on the number of ingested cells and individual sensitivity. Characteristic symptoms of infections caused by Campylobacter spp. infrequently occurring jointly in the clinical form of the disease include: diarrhea, abdominal pain and increased temperature. In the majority of cases the disease is mild and lasts from 2 to 7 days. Usually Campylobacter are excreted with feces during a period of 7-21 days, sometimes even longer. Occasionally in the increased risk group dangerous complications may occur. They include: bacteremia, meningo-myelitis, neurological disturbances and reactive arthritis.

Słowa kluczowe

EN

food hazard; microbiological hazard; Campylobacter; infection development; pathogenic mechanism; complication; campylobacteriosis; pathogenicity; risk group

• Wydawca: -
• Czasopismo: Polish Journal of Veterinary Sciences
• Rocznik: 2009
• Tom: 12
• Numer: 2
• Strony: 285-291
• Opis fizyczny: p.285-291,ref.

Twórcy

autor

Wysok B.

• University of Warmia and Mazury in Olsztyn, Oczapowskiego 14, 10-957 Olsztyn-Kortowo II, Poland

autor

Uradzinski J.

Bibliografia

• Ang CW, van Doom PA, Enoltz HP, Merkies IS, Jacobs BC, de Klerk MA, van Koningsreld R, van der Meche FG (2000) A case of Guillain-Barre syndrome following a family outbreak of Campylobacter jejuni enteritis. J Neuroimmuonol 111: 229-233.
• Akiba T, Akiba K, Suto N, Kumagai K-I, Sakamoto M, Yazaki N (2002) Campylobacter coli bacteriemia in an 11 - year - old boy. Pediatr Int 44: 543-544.
• Asbury AK (2000) New concepts of Guillan - Barre syn­drome. J Child Neurol 15: 183-191.
• Baig BH, Wachsmuth IK, Morris GK (1986) Utilization of exogenous siderophores by Campylobacter species. J Clin Microbiol 2: 431-433.
• Black RE, Levine MM, Clements ML, Hughes TP, Blaser MJ (1988) Experimental Campylobacter jejuni infection in humans. J Infect Dis 157: 472-479.
• Blaser MJ, Sazie E, Williams LP (1987) The influence of immunity on raw milk - associated Campylobacter infec­tion. JAMA 257: 43-46.
• Calin A, Marks SH (1980) Reactive arthritis. Br Med J 281: 311-312.
• Calva JJ, Ruiz-Palacios GM, Lopez - Vidal AB, Ramos A, Bojalil R (1988) Cohort study of intestinal infection with Campylobacter in Mexican children. Lancet 1: 503-506.
• Daczkowska-Kozon E (2002) Epidemiologia zakażeń wywoływanych przez pałeczki z rodzaju Campyloabcter. II. Żywność pochodzenia zwierzęcego jako nośnik Cam­pylobacter sp. Post Mikrobiol 41: 147-166.
• Daczkowska-Kozon E (2004) Co wiemy i czego nie wiemy o Campylobacter sp. Post Mikrobiol 41: 85-104.
• Daczkowska-Kozon E, Brzostek-Nowakowska J (2001) Campylobacter spp. in three main Wetsren Pomerania water bodies. Int J Hyg Environ Health 203: 435-443.
• Dzierżanowska D, Rożynek E (1988) Rola mikroaerofilnych pałeczek Campylobacter jejuni / coli w zakażeniach przewodu pokarmowego. Post Mikrobiol 27: 137-155.
• Frost JA (2001) Current epidemiological issues in human campylobacteriosis. J Appl Microbiol 90: 85-95.
• Grabowska A, Wyszyńska A, Jagusztyn-Krynicka EK (2004) Powrót chorób infekcyjnych: Campylobacter nowy groźny ludzki enteropatogen. Mikrobiol Med 39: 8-15.
• Hannu T, Mattila L, Rautelin H, Pelkonen P, Lahdenne P, Siitonen A Leirisalo-Repo M (2002) Campylobacter-trig­gered reactive arthritis: a population-based study. Rheu­matol 41: 312-318.
• Hickey TE, Bagar S, Bourgeois AL, Ewing CP, Guerry P (1997) Campylobacter jejuni by human peripheral monocytes / macrophages. Med Microbiol Immunol 186: 139-144.
• Hu L, Kopecko DJ (1999) Campylobacter jejuni 81-176 asso­ciates with microtubulea and dynein during invasion of human intestinal cells. Infect Immun 67: 4171-4282.
• Hugdahl MB, Beery JT, Doyle MP (1988) Chemotactic bahavior of Campylobacter jejuni. Infect Immun 56: 1560- -1566.
• Hughes RA, Hadden RD, Gregson NA, Smith KJ (1999) Pathogenesis of Guillain-Barre syndrome. J Neuroim- munol 100: 74-97.
• Jagusztyn-Krynicka EK, Brzuszkiewicz E (2003) Zmienność genetyczna Campylobacter jejuni. Post Mikrobiol 42: 67- -85.
• Keener KM, Bashor MP, Curtis PA, Sheldon BW, Kathariou S (2004) Comprehensive review of Campylobacter and poultry processing. Inst Food Technol 3: 105-116.
• Keener KM, Bashor MP, Curtis PA, Sheldon BW, Kathariou S (2004) Comprehensive review of Campylobacter and poultry processing. Inst Food Technol 3: 105-116.
• Klipstein FA, Engert RF (1984a) Properties of crude Cam­pylobacter jejuni heat-labile enterotoxin. Infect. Immun., 45, 314-319.
• Klipstein FA, Engert RF (1984b) Purification of Cam­pylobacter jejuni enterotoxin. Lancet 67: 1123-1124.
• Klipstein FA, Engert RF, Short H, Schenk EA (1985) Pathogenic properties of Campylobacter jejuni: assay and correlation with clinical manifestation. Infect Immun 58: 43-49.
• Lastovica AJ, Penner JL (1983) Serotypes of Campylobacter jejuni and Campylobacter coli in bacteremic, hospitalized children. J Infect Dis 147-592.
• Mishu B, Blaser MJ (1975) Campylobacter jejuni and the expanding spectrum of related infections. Clin Infect Dis 20: 1091-1098.
• Moran AP, Upton ME (1996) Factors affecting production of coccoid forms by Campylobacter jejuni on solid media during incubation. J Appl Bacteriol 62: 527-537.
• Murphy C, Carroll C, Jordan KN (2006) Environmental sur­vival mechanisms the foodborne pathogen Campylobacter jejuni. J Appl Microbiol 100: 623-632.
• Nachamkin J, Mishu Alios B, Ho T (1998) Campylobacter species and Guillan-Barre Syndrome. Clin Microbiol Rev 11: 555-567.
• Nachamkin J, Yang XH (1989) Human antibody response to Campylobacter jejuni flagellin protein and a synthetic N-terminal flagellin peptide. J Clin Microbiol 27: 2195- -2198.
• Neisser A, Bernheimer H, Berger T, Moran AP, Schwerer B (1997) Serum antibodies against gangliosides and Campylobacter jejuni lipopolysaccharides in Miller-Fisher syndrome. Infect Immun 65: 4038-4042.
• Notermans S (1994) Epidemiology and surveillance of Cam­pylobacter infections. In: Report on a WHO Consultation on Epidemiology and Control of Campylobacteriosis. Bil- thoven, Niederlande 25-27 April, pp 35-44.
• Nuijten PJM, van Asten FJAM, Gaastra W, van der Zeijst BAM (1990) Structural and functional analysis of two Campylobacter jejuni flagellin genes. J Biol Chem 265: 17798-17804.
• Nylen G, Dunstan F, Palmer SR, Andersson Y, Bager F, Cowden J, Feierl G, Galloway Y, Kapperud G, Megraud F, Molbak K, Petersen R, Ruutu P (2002) The seasonal distribution of Campylobacter infection in nine European countries and New Zealand. Epidemiol Infect 128: 383- -390.
• Pavlovskis OR, Rollins DM, Haberberger RL, Green AE, Habash L, Strocko S, Walker RI, (1991) Significance of flagella in colonization resistance of rabbits immunized with Campylobacter spp. Infect Immun 59: 2259-2264.
• Philips CA (1995) Incidence, epidemiology and prevention of foodborne Campylobacter species. Trends Food Sci Tech 6: 81-86.
• Pickett CL, Auffenberg T, Pesci EC, Shenn VL, Jusuf SS (1992) Iron acquisition and hemolysin production by Campylobacter jejuni. Infect Immun 60: 3872-3877.
• Purdy D, Park SF (1994) Cloning, nucleotide sequence and characterization of a gene encoding superoxide dismutase from Campylobacter jejuni and Campylobacter coli. Microbiology 140: 1203-1208.
• Reed RP, Friedland IR, Wegerhoff FO, Khoosal M (1996) Campylobacter bacteremia in children. Pediatr Infect Dis J 15: 345-348.
• Richardson PT, Park SF (1995) Enterochelin acquisition in Campylobacter coli: characterisation of components of a binding protein-dependent transport system. Microbiol­ogy 141: 3181-3191.
• Ropper AH (1992) The Guillan - Barre syndrom. N Engl J Med 326: 1130-1136.
• Shaw I (2003) Risk profile: Campylobacter jejuni/coli in poultry (whole and pieces). Client Report FW01-09.
• Sorvillo FJ, Lieb LE, Wateriman SH (1991) Incidence of cam­pylobacteriosis among patients with AIDS in Los Angeles Country. J Acquir Immune Defic Syndr 4: 598-602.
• Spelman DW, Davidson N, Buckmaster ND, Spiecer WJ, Ryan P (1986) Campylobacter bacteriemia: a report of 10 cases. Med J Aust 145: 503-505.
• Studahal A, Andersson Y (2000) Risk factors for indigenous Campylobacter infections: a Swedish case - control study. Epidemiol Infect 125: 269-275.
• Takata T, Fujimoto S, Amako K (1992) Isolation of non- chemotactic mutants of Campylobacter jejuni and their colonization of the mouse intestinal track. Infect Immun 60: 3596-3600.
• Taylor DN, Echeverría P, Pitarangsi C, Seriwatana J, Bod- hidatta L, Blaser MJ (1988) Influence of strain character­istics and immunity on the epidemiology of Campylobac­ter infections in Thailand. J Clin Microbiol 26: 863-868.
• Taylor DN, Perlman D, Echeverría PD, Lexomboon U, Blaser MJ (1993) Campylobacter immunity and quanti­tative excretion rates in Thai children. J Infect Dis 168: 754-758.
• Teunis PF, Nagelkerke NJ, Hass CN (1999) Dose response models for infections gastroenteritis. Risk Anal 19, 1251- -1260.
• Wallace JS, Stanley KN, Jones K (1998) The colonization of turkeys by thermophilic Campylobacters. J Appl Microbi­ol 85: 224-230.
• Wallis MR (1994) The pathogenesis of Campylobacter jejuni. Br J Biomed Sci 51: 57-64.
• Wassenaar TM (1997) Toxin production by Campylobacter spp. Clin Microbiol Rev 10: 466-476.
• Wieczorek K, Osek J (2005) Campylobacter - przyczyna zakażeń pokarmowych. Med Weter 61: 847-851.
• Windsor DK, Mathewson JJ, Dupony HL (1986) Western blot analysis of intestinal secretory immunoglobulin A re­sponse to Campylobacter jejuni antigens in patients with naturally acquired Campylobacter enteritis. Gastroen­terology 90: 1217-1222.
• Wolf TF, Duim B, Geelsen SP, Rigter A, Thompson - Carter F, Fleer A, Wagenaar JA (2001) Neonatal sepsis by Campylobacter jejuni: geneticaly proven transmission from a household puppy. Clin Infect Dis 32: 97-99.
• Wooldridge KG, Ketley JM (1997) Campylobacter - host cell interactions. Trend Microbiol 5: 96-102.
• Yao R, Burr DH, Guerry P (1997) CheY - mediated modu­lation of Campylobacter jejuni virulence. Molec Microbiol 23: 1021-1031.
• Yuki N, Taki T, Inagaki F, Kasama T, Takahashi M. Sa:: : K. Handa S, Miyatake T (1993) A bacterium lipopolysac­charide that elicits Guillain-Barré syndrome has a GM1 ganglioside-like structure. J Exp Med 178: 1771-1775.
• Ziprin RL, Young CR, Stanker LH, Hume ME, Konkel ME (1999) The absence of cecal colonization of chickens by a mutant of Campylobacter jejuni not expressing bacterial fibronektin - binding protein. Avian Dis 43: 586-589.